October brought us 26 novel publications on psychedelics as medicine. Several studies explored the effects of low doses of LSD, others investigated the positive outcomes of ketamine, whilst some dove into the outcomes of MDMA. Some of the papers published describe interesting experiments and surveys, although many are reviews.
September brought us nearly 30 new and exciting papers on psychedelics that we’ve added to the database. Some focus on the safety of psychedelics, showing the relative safety of LSD in clinical use for instance. Well-being after the ceremonial or therapeutic use of psychedelics and ego-dissolution as a possible mechanism is also explored.
Psychedelic research continued at pace during the summer of 2021. New research focusing on the risks of psychedelics, the benefits when treating addictions, knowledge of different groups about psychedelics, and much more.
Psychedelic research in June continued the path towards making psychedelics available as medicines. From those who use mental health services to the general public, everyone has to get on board before we can get there.
Psychedelic research in May saw the MAPS MDMA study data, psychedelics and genes, and many psychedelic center studies.
Psychedelic research in April pitted psychedelics against SSRIs, gave mice a break from tripping, and found new psychedelics. As we’re awaiting the full results of the MAPS Phase III MDMA trial data, let’s look back at the research of last month.
March was another exceptional month for psychedelics research. March 2021 started with the largest microdosing study with psilocybin, LSD, and other psychedelics
It was another great month for psychedelic research. The BIMA study was the first to use MDMA-assisted psychotherapy for alcoholism (AUD)
Psychedelic research in January 2021 continued at the pace set by the last year. Looking back at research done previously, a meta-analytic review found psychedelics to improve the mood of patients with depression.
This December, research looked into many different aspects of the psychedelic experience. A review paper put forth the argument on why psychedelics and nature (relatedness) should go hand in hand. Music during psychedelic-assisted therapy is at least as important and we saw the first investigation of different genres at the very end of this year.